This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Drug Therapy, Other  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic

Rodrigo Schwartz, MD; Esteban Avello, MD; Francis Palisson, MD

Arch Dermatol. 2008;144(6):724-726.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

Toxic epidermal necrolysis is a life-threatening skin disease. Our case is an attempt to improve its outcome using a novel coadjuvant treatment plan.

REPORT OF A CASE

A 36-year-old Chilean woman with depressive disorder was prescribed treatment with lamotrigine starting at a dosage of 25 mg/d and increasing 25 mg per week. When she reached 75 mg/d at the third week, she presented with an acute abdominal skin eruption. She was evaluated in an emergency department and received 1 dose of sodium phosphate betamethasone and dexchlorpheniramine maleate, 5.3 mg, intravenously, which resulted in partial relief of symptoms for a few hours. The following day she presented with fever with a body temperature up to 38.5°C and a generalized erythematous maculopapular skin eruption, along with few bullae on friction-prone areas and erosions on her oral mucosa and lips. In the next hours, the eruption rapidly became . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT

AUTHOR INFORMATION

Servicio de Dermatología, Hospital Clínico Universidad de Chile, and Departamento de Dermatologia, Clinica Las Condes (Dr Schwartz), Debra-Chile Foundation (Drs Schwartz, Avello, and Palisson), and Departamento de Dermatología, Facultad de Medicina, Universidad del Desarrollo-Clinica Alemana (Dr Palisson), Santiago, Chile